Skip to main content
. Author manuscript; available in PMC: 2020 Dec 5.
Published in final edited form as: Lancet HIV. 2019 Dec 6:S2352-3018(19)30337-6. doi: 10.1016/S2352-3018(19)30337-6

Figure 3:

Figure 3:

Kaplan Meier curves comparing oligonucleotide ligation assay guided therapy versus standard of care on combined end point of time to death, loss to follow-up or virologic failure*

Abbreviations: OLA, oligonucleotide ligation assay; SOC, standard of care

*The graph indicates the number of participants at risk at each time point and the number experiencing combined end point of virologic failure, death, or loss to follow-up in parenthesis.